Pricing Log in Create free account

Champions Oncology, Inc. (CSBR) vs OS Therapies Incorporated (OSTX)

Champions Oncology, Inc. and OS Therapies Incorporated are both Biotechnology companies. Champions Oncology, Inc. and OS Therapies Incorporated are of similar size ($66.7M and $66.0M). OS Therapies Incorporated has the higher net margin (0.00% vs −1.87%) and the higher return on invested capital (0.00% vs −626.2%). Across the 11 metrics below, OS Therapies Incorporated leads on 6 and Champions Oncology, Inc. on 5.

Valuation

Metric CSBR OSTX Biotechnology median
P/E n/m n/m 8.50
P/S 1.08 n/m 9.71
P/B 14.65 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 196.33 n/m 0.64
EV/Sales 1.01 n/m 9.21
Earnings yield (1.70%) (82.58%) (33.15%)
Free cash flow yield (9.36%) (31.98%) (25.50%)

Profitability

Metric CSBR OSTX Biotechnology median
Gross margin 49.82% — 65.16%
Operating margin (1.68%) 0.00% 0.00%
Net margin (1.87%) 0.00% 0.00%
Free cash flow margin (10.08%) 0.00% 0.00%
Return on equity (28.38%) 1,129.52% (56.36%)
Return on assets (3.56%) (389.65%) (48.04%)
Return on invested capital (626.23%) 0.00% 0.00%

Growth

Metric CSBR OSTX Biotechnology median
Revenue growth (TTM) 6.65% — 6.02%
EPS growth (last fiscal year) (124.24%) 23.32% 30.26%
Revenue growth, 5-year CAGR 7.68% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CSBR OSTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.03 0.18 4.72
Net debt to EBITDA (20.56) 0.01 0.96

Dividend

Metric CSBR OSTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CSBR OSTX Biotechnology median
Market cap 66.67m 66.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack